-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Verona Pharma plc quarterly and annual Revenues in USD history and change rate from 30 Sep 2020 to 30 Jun 2025.
- Verona Pharma plc Revenues for the quarter ending 30 Jun 2025 was $103,138,000.
- Verona Pharma plc Revenues for the twelve months ending 30 Jun 2025 was $221,673,000.
- Verona Pharma plc annual Revenues for 2024 was $42,279,000.
- Verona Pharma plc annual Revenues for 2023 was $0, a 100% decline from 2022.
- Verona Pharma plc annual Revenues for 2022 was $458,000, a 99% decline from 2021.